Title: Global Intravenous (IV) Iron Drugs Market Report: 2016 Edition - New Report by Koncept Analytics
1Global I.V. Iron Drugs Market Report
----------------------------------------- 2016
View Report Details
2View Report Details
- Executive Summary
- Iron is vital for multiple bodily functions, most
importantly for the production of hemoglobin for
red blood cells which are responsible for
transporting oxygen in the blood. As an element,
the only source of iron is from the diet. There
is no way the body can produce iron itself.
Intravenous (IV) treatment, in a broad sense,
covers all the types of medications delivered
intravenously, i.e. directly into the vein,
through intravenous drip. Compared to the other
routes of infusing medications, the intravenous
route is the fastest way to deliver fluids and
medications throughout the body. The first iron
product for intravenous use was
high-molecular-weight iron dextran. Some of the
major areas of IV iron application include
gynecology, gastroenterology, oncology and
surgeries. Hemoglobin, Ferritin, Transferrin, and
Hepcidin are major molecules which are critical
in the function and regulation of iron. - The key factors driving growth of the global I.V.
iron industry include increase in number of
dialysis cases, increasing global healthcare
expenditures, rising ageing population,
increasing life expectancy rate, growing number
of ERSD patients and rising medicines
expenditures. Some of the noteworthy trends and
developments of this industry are new product
development, introduction of the first generation
drugs InFed (iron dextran) and Dexeferrum (iron
dextra) and feraccru treatment penetration.
However, the growth of this sector is being
hindered by emerging anemia management therapies
and associated risks. - The report analyzes the global iron products
industry along with an extensive coverage of
global, Europe and the US I.V. iron market. The
global IV iron market witnesses intense
competition with numerous top notch players such
as Galenica Pharmaceuticals, Actavis Inc, AMAG
Pharmaceuticals operating in the marketplace
along with small budding players. As a part of
analysis of fierce competition prevailing in the
industry, product contention has been presented
in the report. The company profiles of leading
aforementioned players in the market are also
incorporated in the report. - By combining SPSS Inc.s data integration and
analysis capabilities with our relevant findings,
we have predicted the future growth of the
industry. We employed various significant
variables that have an impact on this industry
and created regression models with SPSS Base to
determine the future direction of the industry.
Before deploying the regression model, the
relationship between several independent or
predictor variables and the dependent variable
was analyzed using standard SPSS output,
including charts, tables and tests.
3Growing number of dialysis patients, ageing
population and ERSD patients to drive the market
Global I.V. Iron Drugs Market by Value (2010-2015)
- The global I.V. iron market was valued at US...
million in 2015, as compared to US... million in
2013, showing an incline of . - As of 2015, in terms of product category, Venofer
accounted for the largest market share of in
the global I.V. iron market, followed by
Ferinject with of the market share. ISS and
Feraheme held and share of the total
respectively. - As of 2015, oral iron products held the largest
share of share in the global iron products
market, followed by intravenous products with
share of .
Global I.V. Iron Drugs Market Share by Product
(2015)
Global Iron Products Market Share by Segment
(2015)
4Increasing healthcare expenditure and economic
development are also driving the market.
The US I.V. Iron Drug Market by Value (2010-2015)
- The US I.V. iron market marked an incline of
to reach US... million in 2015, as compared to
US... million in the prior year. - As of 2015, Venofer accounted for the largest
market share of in the total US I.V. iron
market followed by Injectafer with share of .
Feraheme and Gluconate held and share
respectively. - As of 2015, European I.V. iron drug market
declined by to reach US... million, due to
currency fluctuation.
The US I.V. Iron Drug Market Share by Product
(2015)
European I.V. Iron Drug Market by Value
(2010-2015)
5The future growth would mainly be driven by
growing ERSD patients, increasing cases of
hypertension and number of dialysis patients.
Global I.V. Iron Drug Market Forecast (2014-2019E)
- The global I.V. iron drugs market is estimated to
grow at a CAGR of from US... million in 2014
to US... million in 2019. - The global I.V. iron drugs market is showing a
significant growth owing to improvement in the
quality of treatment outside dialysis, increasing
number of dialysis patients, growing number of
ERSD patients worldwide and growing ageing
population.
6Contact Us
View Report Details
These are abridged and sanitized sample pages
from the comprehensive report on the Global
I.V. Iron Drugs Market . To know more about
this report or for any customized research
requirement, please contact the following
Koncept Analytics CS-36, Second Floor, Ansal
Plaza Vaishali, Ghaziabad, U.P. 201010 T.
91-120-4130959 C 91-9811715635
vikas_at_konceptanalytics.com
Vikas Gupta BD Manager
www.konceptanalytics.com